TGFB1 and Hepatic fibrosis: Pirfenidone inhibits platelet-derived growth factor-induced proliferation and collagen production in hepatic stellate cells [34], and reduced expression of procollagen α1 and tissue inhibitors of metalloproteinase-1 through the downregulation of TGF-β1 mRNA in the rat liver fibrosis model [35].